Original Research
Accepted on 27 Feb 2026
MG53 Protects Against Intestinal Inflammation by Inhibiting NLRP3 Inflammasome Activation
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 27 Feb 2026
in Experimental Pharmacology and Drug Discovery
Brief Research Report
Accepted on 27 Feb 2026
in Addictive Disorders
Original Research
Accepted on 27 Feb 2026
in Forest Management
Correction
Accepted on 27 Feb 2026
in Drug Delivery for Special Patient Populations
Original Research
Accepted on 27 Feb 2026
in Agricultural and Food Economics
Review
Accepted on 27 Feb 2026
in Higher Education
Original Research
Accepted on 27 Feb 2026
in Safe and Just Resource Management
Systematic Review
Accepted on 27 Feb 2026
in Higher Education
Original Research
Accepted on 27 Feb 2026
in Children and Health
Mini Review
Accepted on 27 Feb 2026
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 27 Feb 2026
in Mathematical Biology
Original Research
Accepted on 27 Feb 2026
in Pharmacology of Infectious Diseases
Brief Research Report
Accepted on 27 Feb 2026
in Space Physics
Original Research
Accepted on 27 Feb 2026
in Agricultural and Food Economics
Editorial
Accepted on 27 Feb 2026
Case Report
Accepted on 27 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders